Cooper Companies | COO - Operating Profit

Stock Price
59.61
Daily Change
-0.77 -1.28%
Monthly
-14.08%
Yearly
-28.11%
Q2 Forecast
58.41

Cooper Companies reported $212.8M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Abbott USD 1.85B 399M Mar/2026
Align Technology USD 178.05M 46.66M Mar/2026
AtriCure USD 526K 1.96M Mar/2026
Avanos Medical USD 8.9M 15.87M Mar/2026
Bausch Health Companies USD 489M 230M Mar/2026
Baxter International USD 66M 280.2M Mar/2026
Bayer EUR 3.53B 2.42B Mar/2026
Becton, Dickinson and Co. USD 627M 36M Mar/2026
Boston Scientific USD 1.05B 190M Mar/2026
Cooper Companies USD 212.8M 72.4M Dec/2025
Dentsply International USD 32M 506M Mar/2026
Dexcom USD 255.3M 67.7M Mar/2026
Edwards Lifesciences USD 514.7M 144.4M Mar/2026
Globus Medical USD 164M 17.31M Mar/2026
Haemonetics USD 67.4M 8.9M Dec/2025
Inogen USD -7.79M 728K Sep/2024
Insulet USD 122M 24.3M Mar/2026
Integra LifeSciences USD 11.47M 54.54M Mar/2026
Intuitive Surgical USD 859.7M 5.6M Mar/2026
J&J USD 6.62B 1.03B Mar/2026
Medtronic USD 1.74B 40M Dec/2025
Merit Medical Systems USD 44.16M 10.04M Mar/2026
Novartis USD 4.06B 521M Dec/2025
ResMed USD 505.67M 8.07M Mar/2026
STAAR Surgical USD 17.4M 28.34M Mar/2026
Steris USD 318.7M 40.7M Mar/2026
Stryker USD 1.1B 867M Mar/2026
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teleflex USD 37.03M 686K Mar/2026
Utah Medical Products USD 2.44M 1.32M Dec/2025
Zimmer Biomet Holdings USD 395.1M 92.2M Mar/2026